Juvaris gets infusion for infectious disease vaccines | VentureBeat
DEALS.VENTUREBEAT.COM - Juvaris BioTherapeutics, a Burlingame, Calif.-based developer of vaccines to treat infectious diseases, announced that it raised financing toward its targeted $25 million second round of funding from SV Life Sciences and Kleiner Perkins Caufield & Byers. The company wouldn’t put a finer point on the amount, mostly because it is open to further investments in the round.The money will give...
First tweeted by camillericketts.
From the Front Page
Socialsafe.net
- Comments
- Tweets (15)
Tweets
Sorry there have been no tweets in the last 7 days.
